These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5302873)

  • 1. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 3. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sedalium in psychiatry within its tranquilizing and neuroleptic boundaries].
    Volmat R; Beaudouin JL; Allers G; Vittouris N; Dufay F; Bizouard P
    Encephale; 1972; 61(2):163-82. PubMed ID: 4634905
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effects of the butyrophenones. Floropipamide (Dipiperon), methylperon (Buronil), trifluperidol (Psicoperidol)].
    Kristjansen P
    Nord Psykiatr Tidsskr; 1968; 22(3):235-48. PubMed ID: 5711258
    [No Abstract]   [Full Text] [Related]  

  • 7. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
    Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
    Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
    [No Abstract]   [Full Text] [Related]  

  • 9. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
    Denber HC
    Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary observations on the clinical use in psychiatry of a recent derivative of butyrophenone (Luvatrene)].
    Gori EC; Bonasegla F
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1304-14. PubMed ID: 5997230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Character disorders and their treatment by pipamperone].
    Fouks ; Périvier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 13. [Note on the use of dihydrogenated derivatives of ergotoxin (Hydergine) and their association with psychopharmacology in the treatment of aged neuropsychiatric patients].
    Bertolotti P; Spaggiari G
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1243-58. PubMed ID: 4968439
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of trifluperidol therapy.
    Szobor A
    Ther Hung; 1969; 17(3):109-14. PubMed ID: 5356925
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of a new psychopharmacological agent: piperonyl].
    Gazzaniga GC; Terzi GF
    Riv Sper Freniatr Med Leg Alien Ment; 1971 Aug; 95(4):799-807. PubMed ID: 5114798
    [No Abstract]   [Full Text] [Related]  

  • 16. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 17. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical trial with R-3345].
    Bastos O; Carvalho RG
    J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic experiences with oxazepam--a derivative of the benzodiazepine series--in child and adolescent psychiatry].
    Nievoll A
    Wien Klin Wochenschr; 1971 Apr; 83(14):251-4. PubMed ID: 5559790
    [No Abstract]   [Full Text] [Related]  

  • 20. factors influencing response to major tranquilizer medications.
    Kimbell I; Overall JE; Faibish GM; Pokorny AD
    Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.